George S.N. Hui to Antibodies, Protozoan
This is a "connection" page, showing publications George S.N. Hui has written about Antibodies, Protozoan.
Connection Strength
2.147
-
Pusic K, Xu H, Stridiron A, Aguilar Z, Wang A, Hui G. Blood stage merozoite surface protein conjugated to nanoparticles induce potent parasite inhibitory antibodies. Vaccine. 2011 Nov 08; 29(48):8898-908.
Score: 0.381
-
Hui G, Choe D, Hashimoto C. Biological activities of anti-merozoite surface protein-1 antibodies induced by adjuvant-assisted immunizations in mice with different immune gene knockouts. Clin Vaccine Immunol. 2008 Aug; 15(8):1145-50.
Score: 0.304
-
Hui GS, Hashimoto CN. Adjuvant formulations possess differing efficacy in the potentiation of antibody and cell mediated responses to a human malaria vaccine under selective immune genes knockout environment. Int Immunopharmacol. 2008 Jul; 8(7):1012-22.
Score: 0.299
-
Hui G, Hashimoto C. The requirement of CD80, CD86, and ICAM-1 on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccine. Vaccine. 2007 Dec 12; 25(51):8549-56.
Score: 0.290
-
Nagata M, Wong T, Clements D, Hui G. Plasmodium falciparum: immunization with MSP1-42 induced non-inhibitory antibodies that have no blocking activities but enhanced the potency of inhibitory anti-MSP1-42 antibodies. Exp Parasitol. 2007 Apr; 115(4):403-8.
Score: 0.272
-
Hui G, Hashimoto C. Plasmodium falciparum anti-MSP1-19 antibodies induced by MSP1-42 and MSP1-19 based vaccines differed in specificity and parasite growth inhibition in terms of recognition of conserved versus variant epitopes. Vaccine. 2007 Jan 15; 25(5):948-56.
Score: 0.269
-
Pusic K, Clements D, Kobuch S, Hui G. Antibody and T cell responses in reciprocal prime-boost studies with full-length and truncated merozoite surface protein 1-42 vaccines. PLoS One. 2013; 8(9):e75939.
Score: 0.110
-
Hui G, Hashimoto C. Interleukin-6 has differential influence on the ability of adjuvant formulations to potentiate antibody responses to a Plasmodium falciparum blood-stage vaccine. Vaccine. 2007 Sep 04; 25(36):6598-603.
Score: 0.071
-
Yuen D, Leung WH, Cheung R, Hashimoto C, Ng SF, Ho W, Hui G. Antigenicity and immunogenicity of the N-terminal 33-kDa processing fragment of the Plasmodium falciparum merozoite surface protein 1, MSP1: implications for vaccine development. Vaccine. 2007 Jan 05; 25(3):490-9.
Score: 0.067
-
Hui GS, Hashimoto CN. Pathways for potentiation of immunogenicity during adjuvant-assisted immunizations with Plasmodium falciparum major merozoite surface protein 1. Infect Immun. 1998 Nov; 66(11):5329-36.
Score: 0.039
-
Hui GS, Nikaido C, Hashiro C, Kaslow DC, Collins WE. Dominance of conserved B-cell epitopes of the Plasmodium falciparum merozoite surface protein, MSP1, in blood-stage infections of naive Aotus monkeys. Infect Immun. 1996 May; 64(5):1502-9.
Score: 0.033
-
Pang AL, Hashimoto CN, Tam LQ, Meng ZQ, Hui GS, Ho WK. In vivo expression and immunological studies of the 42-kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the baculovirus-silkworm system. Infect Immun. 2002 Jun; 70(6):2772-9.
Score: 0.012